These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


150 related items for PubMed ID: 7756413

  • 21. Studies of human natural killer cytotoxic factor (NKCF): characterization and analysis of its mode of action.
    Ortaldo JR, Blanca I, Herberman RB.
    Adv Exp Med Biol; 1985; 184():203-20. PubMed ID: 3898750
    [Abstract] [Full Text] [Related]

  • 22. Lysis of natural killer-sensitive and -resistant tumor cells by natural killer cytotoxic factors (NKCF)-containing liposomes.
    Roozemond RC, Urli DC, Wright SC, Graves SS, Bonavida B.
    Immunobiology; 1987 Dec; 176(1-2):35-46. PubMed ID: 3447981
    [Abstract] [Full Text] [Related]

  • 23. Analysis of rat natural killer cytotoxic factor (NKCF): mechanism of action and relationship to other cytotoxic/cytostatic factors.
    Winkler-Pickett RT, Young HA, Kuta A, Ortaldo JR.
    Cell Immunol; 1991 Jun; 135(1):42-54. PubMed ID: 2018982
    [Abstract] [Full Text] [Related]

  • 24. Human natural killer cytotoxic factor. Studies on its production, specificity, and mechanism of interaction with target cells.
    Blanca I, Herberman RB, Ortaldo JR.
    Nat Immun Cell Growth Regul; 1985 Jun; 4(1):48-59. PubMed ID: 4033671
    [Abstract] [Full Text] [Related]

  • 25. Impaired release of a soluble natural killer cytotoxic factor in systemic lupus erythematosus.
    Sibbitt WL, Mathews PM, Bankhurst AD.
    Arthritis Rheum; 1984 Oct; 27(10):1095-100. PubMed ID: 6487394
    [Abstract] [Full Text] [Related]

  • 26. Studies on the mechanism of natural killer cell-mediated cytotoxicity. VII. functional comparison of human natural killer cytotoxic factors with recombinant lymphotoxin and tumor necrosis factor.
    Wright SC, Bonavida B.
    J Immunol; 1987 Mar 15; 138(6):1791-8. PubMed ID: 3493288
    [Abstract] [Full Text] [Related]

  • 27. Analysis of rat natural killer cytotoxic factor (NKCF) produced by rat NK cell lines and the production of a murine monoclonal antibody that neutralizes NKCF.
    Ortaldo JR, Winkler-Pickett R, Morgan AC, Woodhouse C, Kantor R, Reynolds CW.
    J Immunol; 1987 Nov 01; 139(9):3159-65. PubMed ID: 3668253
    [Abstract] [Full Text] [Related]

  • 28. Cytotoxic factor produced by human blood lymphocytes of low density upon exposure to autologous B cells.
    Saranath D, Masucci MG, Klein E.
    Immunol Lett; 1986 Mar 01; 12(2-3):141-6. PubMed ID: 3013760
    [Abstract] [Full Text] [Related]

  • 29. Distinction of partially purified human natural killer cytotoxic factor from recombinant human tumor necrosis factor and recombinant human lymphotoxin.
    Bialas T, Kolitz J, Levi E, Polivka A, Oez S, Miller G, Welte K.
    Cancer Res; 1988 Feb 15; 48(4):891-8. PubMed ID: 3257413
    [Abstract] [Full Text] [Related]

  • 30. Soluble cytotoxic factors and the mechanism of NK cell mediated cytotoxicity.
    Bonavida B, Wright SC.
    Adv Exp Med Biol; 1982 Feb 15; 146():379-88. PubMed ID: 7102465
    [Abstract] [Full Text] [Related]

  • 31. A killing defect of natural killer cells with the absence of natural killer cytotoxic factors in a child with Hodgkin's disease.
    Komiyama A, Kawai H, Yamada S, Kato M, Yanagisawa M, Miyagawa Y, Akabane T.
    Blood; 1987 Jun 15; 69(6):1686-90. PubMed ID: 3580573
    [Abstract] [Full Text] [Related]

  • 32. Studies on the mechanism of the human natural killer cell lethal hit: analysis of the mechanism of protease inhibition of the lethal hit.
    Hiserodt JC, Britvan L, Targan SR.
    J Immunol; 1983 Dec 15; 131(6):2705-9. PubMed ID: 6358352
    [Abstract] [Full Text] [Related]

  • 33. Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. IV. Interleukin-1 deficiency, gamma-interferon deficiency and the restorative effects of short-term culture in the presence of interleukin-2 on natural killer cytotoxicity, natural killer-target binding and production of natural killer cytotoxic factor.
    Chang WC, Hsiao MH, Pattengale PK.
    Nat Immun Cell Growth Regul; 1991 Dec 15; 10(2):57-70. PubMed ID: 1881400
    [Abstract] [Full Text] [Related]

  • 34. Sera from patients with colon, breast and lung cancer induce resistance to lysis mediated by NK cytotoxic factors (NKCF).
    Marubayashi M, Solana R, Ramirez R, Aranda E, Galan F, Peña J.
    Br J Cancer; 1991 Jun 15; 63(6):893-6. PubMed ID: 1906292
    [Abstract] [Full Text] [Related]

  • 35. Effects of X-ray irradiation on natural killer (NK) cell system. II. Increased sensitivity to natural killer cytotoxic factor (NKCF).
    Uchida A, Mizutani Y, Nagamuta M, Ikenaga M.
    Immunopharmacol Immunotoxicol; 1989 Jun 15; 11(2-3):521-34. PubMed ID: 2621326
    [Abstract] [Full Text] [Related]

  • 36. Depressed natural cytotoxicity but normal natural killer cytotoxic factor (NKCF) production by mononuclear cells derived from patients with hepatocellular carcinoma.
    Brookes RH, Kew MC, Rabson AR.
    Cancer Immunol Immunother; 1987 Jun 15; 25(2):149-52. PubMed ID: 2822243
    [Abstract] [Full Text] [Related]

  • 37. Inhibition of cytotoxicity by sulfasalazine. II. Sulfasalazine and sulfapyridine inhibit different stages of the NK and NKCF lytic processes.
    Shanahan F, Niederlehner A, MacDermott RP, Stenson WF, Kane MG, Targan S.
    Immunopharmacology; 1986 Apr 15; 11(2):111-8. PubMed ID: 2872187
    [Abstract] [Full Text] [Related]

  • 38. Intrinsic cytotoxicity of natural killer cells to pancreatic islets in vitro.
    Nakamura N, Woda BA, Tafuri A, Greiner DL, Reynolds CW, Ortaldo J, Chick W, Handler ES, Mordes JP, Rossini AA.
    Diabetes; 1990 Jul 15; 39(7):836-43. PubMed ID: 2191887
    [Abstract] [Full Text] [Related]

  • 39. Natural killer cytotoxic factor induction by K562 cells in patients with advanced cancer: correlation with production of interferon.
    Steinhauer EH, Doyle AT, Reed J, Kadish AS.
    J Natl Cancer Inst; 1985 Dec 15; 75(6):1017-23. PubMed ID: 2415742
    [Abstract] [Full Text] [Related]

  • 40. Natural killer (NK) cell activity during HIV infection: a decrease in NK activity is observed at the clonal level and is not restored after in vitro long-term culture of NK cells.
    Scott-Algara D, Vuillier F, Cayota A, Dighiero G.
    Clin Exp Immunol; 1992 Nov 15; 90(2):181-7. PubMed ID: 1424272
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.